| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 678343 | Null | 0.000601164336889762 | 0.54774841 |
| NSC 722854 | 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline | 0.000601164336889762 | 0.40699428 |
| NSC 753456 | 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole | 0.00070132188671658 | 0.36556434 |
| NSC 68091 | WLN: WS3&1U1SW3 -T | 0.000880521445136057 | 0.27156019 |
| NSC 680931 | Null | 0.000880521445136057 | 0.39574313 |
| NSC 749862 | 3-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine | 0.000880521445136057 | 0.45356115 |
| NSC 668300 | Null | 0.000930692338491037 | 0.18884207 |
| NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.000931492155975116 | 0.31012487 |
| NSC 685827 | Null | 0.000931492155975116 | 0.39558142 |
| NSC 724781 | (1S,4R,5R,8R,12R,13S)-9-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl -10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10.3.1. 04,13.08,13]hexadec-9-en-9-yl]methoxy}-2-butenyl)oxy]methyl} -1,5-dimethyl-10 | 0.000931492155975116 | 0.19219869 |